About Aignosis
Aignosis is a company based in Jaipur (India) founded in 2024 by Divyansh Mangal and Raksheet Jain. Aignosis has raised $151.06 thousand across 2 funding rounds from investors including GirnarSOFT, Rajneesh Bhandari and Peyush Bansal. Aignosis operates in a competitive market with competitors including Behavior Imaging Solutions, Autism Detect and BlueSavant, among others.
- Headquarter Jaipur, India
- Founders Divyansh Mangal, Raksheet Jain
-
Sectors
HealthcareConsumer
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aignosis Artificial Intelligence Private Limited
- Date of Incorporation 06 May, 2024
- Jurisdiction Jaipur, Rajasthan, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$151.06 K (USD)
in 2 rounds
-
Latest Funding Round
$115.65 K (USD), Angel Round
Jan 24, 2025
-
Investors
GirnarSOFT
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Aignosis
Aignosis has successfully raised a total of $151.06K across 2 strategic funding rounds. The most recent funding activity was a Angel Round of $115.65 thousand completed in January 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Aignosis
Aignosis has secured backing from 5 investors, including institutional and angel investors. Prominent investors backing the company include GirnarSOFT, Rajneesh Bhandari and Peyush Bansal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provider of website, web & mobile application development, BI, and digital marketing services
|
Locked | Locked | Locked | |
|
RB
Rajneesh Bhandari |
-
|
Locked | Locked | Locked |
|
PB
Peyush Bansal |
Founder of Lenskart, prominent angel investor, Shark Tank India judge
|
Locked | Locked | Locked |
Investor details for Aignosis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aignosis
Investment portfolio details for Aignosis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aignosis
Detailed financials for Aignosis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aignosis Comparisons
Peer comparison for Aignosis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aignosis
Aignosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Behavior Imaging Solutions, Autism Detect and BlueSavant, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides telehealth tools for autism diagnosis, mental health, and special education assessments.
|
|
| Locked | Locked | Locked |
An online platform providing autism assessments for adults and children.
|
|
| Locked | Locked | Locked |
Offers AI-driven blood tests for early autism diagnosis in children.
|
Detailed competitors of Aignosis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aignosis
Complete news archive for Aignosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aignosis
Aignosis was founded in 2024.
Aignosis is headquartered in Jaipur, India. It is registered at Jaipur, Rajasthan, India.
Divyansh Mangal is the current CEO of Aignosis. They have also founded this company.
Aignosis is a funded company, having raised a total of $151.06K across 2 funding rounds to date.
Platform offering AI-based solutions for early autism screening and detection. It offers autism assessments, psychological evaluations, and specialized care solutions, including educational support for children with autism. It provides digital tools for early autism screening and diagnosis, utilizing artificial intelligence to support families and clinicians in identifying autism spectrum disorders at an early stage.
Aignosis's top competitors include Behavior Imaging Solutions, Autism Detect and BlueSavant.
Aignosis has 5 investors. Key investors include GirnarSOFT, Rajneesh Bhandari, Peyush Bansal, Aman Gupta, and Varun Dua.
The valuation of Aignosis is $840.77K as of Dec 2024.